Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Pedro M. Lacal
Thrombospondin-1 Is Part of a Slug-Independent Motility and Metastatic Program in Cutaneous Melanoma, in Association With VEGFR-1 and FGF-2
Pigment Cell and Melanoma Research
Biochemistry
Dermatology
Oncology
Genetics
Molecular Biology
Neuropilin-1 as Therapeutic Target for Malignant Melanoma
Frontiers in Oncology
Cancer Research
Oncology
Related publications
Claudin-1 Overexpression in Melanoma Is Regulated by PKC and Contributes to Melanoma Cell Motility
Oncogene
Cancer Research
Genetics
Molecular Biology
Analysis of Biological Effects and Signaling Properties of FLT-1 (VEGFR-1) and KDR (VEGFR-2)
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Retinal Vasculitis and Ocular Vitreous Metastasis Following Complete Response to PD-1 Inhibition in a Patient With Metastatic Cutaneous Melanoma
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
459 the FGF-2 Binding Domain of Thrombospondin-1: Functional Characterization and Exploitation to Design Antiangiogenic Compounds
European Journal of Cancer, Supplement
Cancer Research
Oncology
Promoter Polymorphisms in Matrix Metallopeptidase 1 and Risk of Cutaneous Melanoma
European Journal of Cancer
Cancer Research
Oncology
Differentiation-Inducing Factor-1 Exhibits Anti-Metastatic Effects by Inhibiting Cellular Motility and Adhesion in Malignant Melanoma Cells
Proceedings for Annual Meeting of The Japanese Pharmacological Society
The COX2 Effector Microsomal PGE2 Synthase-1 Is a Regulator of Immunosuppression in Cutaneous Melanoma
Clinical Cancer Research
Cancer Research
Oncology
Cutaneous Adverse Events (AEs) of Anti-Programmed Cell Death (PD)-1 Therapy in Patients With Metastatic Melanoma: A Single-Institution Cohort
Journal of the American Academy of Dermatology
Dermatology
Association Between Circulating Tumor DNA and Pseudoprogression in Patients With Metastatic Melanoma Treated With Anti–Programmed Cell Death 1 Antibodies
JAMA Oncology
Cancer Research
Oncology